HCW Biologics Inc. (HCWB) Tops Q2 EPS by 4c
Tweet
Share
E-mailGet Alerts HCWB Hot Sheet
Join SI Premium – FREE
HCW Biologics Inc. (NASDAQ: HCWB) reported Q2 EPS of ($0.10), $0.04 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $454 thousand versus the consensus estimate of $0 .
For earnings history and earnings-related data on HCW Biologics Inc. (HCWB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- Tenaris SA (TS) Tops Q1 EPS by 22c; offers outlook
- Edwards Lifesciences (EW) Tops Q1 EPS by 2c; offers guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
